# Study of STP938 in Advanced Solid Tumours

> **NCT06297525** · PHASE1 · RECRUITING · sponsor: **Step Pharma, SAS** · enrollment: 70 (estimated)

## Conditions studied

- Solid Tumor

## Interventions

- **DRUG:** STP938

## Key facts

- **NCT ID:** NCT06297525
- **Lead sponsor:** Step Pharma, SAS
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-02
- **Primary completion:** 2026-12
- **Final completion:** 2027-05
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2026-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06297525

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06297525, "Study of STP938 in Advanced Solid Tumours". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT06297525. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*